Gregory H. Pelton

8.6k total citations · 2 hit papers
83 papers, 6.3k citations indexed

About

Gregory H. Pelton is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Gregory H. Pelton has authored 83 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Psychiatry and Mental health, 22 papers in Pharmacology and 22 papers in Cognitive Neuroscience. Recurrent topics in Gregory H. Pelton's work include Dementia and Cognitive Impairment Research (34 papers), Treatment of Major Depression (21 papers) and Schizophrenia research and treatment (16 papers). Gregory H. Pelton is often cited by papers focused on Dementia and Cognitive Impairment Research (34 papers), Treatment of Major Depression (21 papers) and Schizophrenia research and treatment (16 papers). Gregory H. Pelton collaborates with scholars based in United States, Canada and United Kingdom. Gregory H. Pelton's co-authors include Davangere P. Devanand, Yaakov Stern, Matthias H. Tabert, Lawrence H. Price, Karen L. Bell, Karen Marder, D. P. Devanand, Christopher J. McDougle, Xinhua Liu and Gnanavalli Pradhaban and has published in prestigious journals such as Nature, New England Journal of Medicine and JAMA.

In The Last Decade

Gregory H. Pelton

80 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hippocampal and entorhinal atrophy in mild cognitive impairment

2007 578 citations Davangere P. Devanand, Gnanavalli Pradhaban et al. profile →
Effect of Citalopram on Agitation in Alzheimer Disease

2014 353 citations Anton P. Porsteinsson, Lea T. Drye et al. JAMA profile →

Peers

Countries citing papers authored by Gregory H. Pelton

Since Specialization

Citations

This map shows the geographic impact of Gregory H. Pelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory H. Pelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory H. Pelton more than expected).

Fields of papers citing papers by Gregory H. Pelton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory H. Pelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory H. Pelton. The network helps show where Gregory H. Pelton may publish in the future.

Co-authorship network of co-authors of Gregory H. Pelton

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory H. Pelton. A scholar is included among the top collaborators of Gregory H. Pelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory H. Pelton. Gregory H. Pelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Valacyclovir Treatment of Early Symptomatic Alzheimer Disease 2025 ·JAMA ·D. P. Devanand, Thomas Wısnıewskı, Qolamreza Razlighi, Min Qian, Renjie Wei, Howard Andrews, Edward P. Acosta, Karen L. Bell, Gregory H. Pelton, Deborah A. Deliyannides, Amandine Perrin, Elise Caccappolo, Anne A. Gershon, Konasale M. Prasad, William Charles Kreisl, Akiva Mintz, Edward D. Huey	0
2	Sleep–wake behavior, perceived fatigability, and cognitive reserve in older adults 2024 ·Alzheimer s & Dementia ·Nancy Kerner, Terry E. Goldberg, Hannah Cohen, (unknown), Daniel E. Cohen, Howard Andrews, Gregory H. Pelton, Davangere P. Devanand	3
3	Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial 2021 ·American Journal of Geriatric Psychiatry ·Davangere P. Devanand, Elizabeth Crocco, Brent P. Forester, Mustafa M. Husain, Seonjoo Lee, Ipsit V. Vahia, Howard Andrews, (unknown), (unknown), (unknown), Edward D. Huey, Deborah A. Deliyannides, Gregory H. Pelton	37
4	Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial 2020 ·BMJ Open ·Davangere P. Devanand, Howard Andrews, William Charles Kreisl, Qolamreza Razlighi, Anne A. Gershon, Yaakov Stern, Akiva Mintz, Thomas Wısnıewskı, Edward P. Acosta, John Pollina, (unknown), Karen L. Bell, Gregory H. Pelton, Deborah A. Deliyannides, Konasale M. Prasad, Edward D. Huey	52
5	Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial 2018 ·American Journal of Geriatric Psychiatry ·Davangere P. Devanand, Gregory H. Pelton, (unknown), Adam Ciarleglio, Jennifer Scodes, Howard Andrews, (unknown), John L. Beyer, Jeffrey R. Petrella, Joel R. Sneed, (unknown), P. Murali Doraiswamy	34
6	Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study 2016 ·American Journal of Geriatric Psychiatry ·Nancy Kerner, Steven P. Roose, Gregory H. Pelton, Adam Ciarleglio, Jennifer Scodes, Cody Lentz, Joel R. Sneed, Davangere P. Devanand	19
7	Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease 2015 ·American Journal of Geriatric Psychiatry ·Daniel Weintraub, Lea T. Drye, Anton P. Porsteinsson, Paul B. Rosenberg, Bruce G. Pollock, Devangere Devanand, Constantine Frangakis, Zahinoor Ismail, Christopher Marano, Curtis L. Meinert, Jacobo Mintzer, Cynthia A. Munro, Gregory H. Pelton, Peter V. Rabins, Lon S. Schneider, David Shade, Jerome A. Yesavage, Constantine G. Lyketsos	19
8	Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): Clinical rationale and design 2013 ·Contemporary Clinical Trials ·Gregory H. Pelton, Howard Andrews, Steven P. Roose, Sue M. Marcus, (unknown), (unknown), Jeffrey R. Petrella, Anthony S. Zannas, P. Murali Doraiswamy, Davangere P. Devanand	14
9	A randomized, prospective pilot study of patient expectancy and antidepressant outcome 2012 ·Psychological Medicine ·(unknown), S. Marcus, Peng Wang, Joel R. Sneed, Gregory H. Pelton, Davangere P. Devanand, Naihua Duan, Steven P. Roose	35
10	Predictive Utility of Type and Duration of Symptoms at Initial Presentation in Patients with Mild Cognitive Impairment 2010 ·Dementia and Geriatric Cognitive Disorders ·Deidre Devier, Nicole R. Villemarette-Pittman, Patrick J. Brown, Gregory H. Pelton, Yaakov Stern, Mary Sano, Davangere P. Devanand	24
11	Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease 2008 ·Biological Psychiatry ·Davangere P. Devanand, Xinhua Liu, Matthias H. Tabert, Gnanavalli Pradhaban, Katrina Cuasay, Karen L. Bell, Mony J. de Leon, Richard L. Doty, Yaakov Stern, Gregory H. Pelton	296
12	Predictive Utility of Apolipoprotein E Genotype for Alzheimer Disease in Outpatients With Mild Cognitive Impairment 2005 ·Archives of Neurology ·D. P. Devanand, Gregory H. Pelton, Diana Zamora, Xinhua Liu, Matthias H. Tabert, Madeleine S. Goodkind, Nikolaos Scarmeas, Ilana M. Braun, Yaakov Stern, Richard Mayeux	93
13	Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance 2004 ·NeuroImage ·Nikolaos Scarmeas, Christian Habeck, Eric Zarahn, Karen E. Anderson, Aileen Park, John Hilton, Gregory H. Pelton, Matthias H. Tabert, Lawrence S. Honig, James R. Moeller, Davangere P. Devanand, Yaakov Stern	86
14	The impact of mild cognitive impairment on functional abilities in the elderly 2002 ·Current Psychiatry Reports ·Steven M. Albert, (unknown), (unknown), Gregory H. Pelton, Devangere Devanand	36
15	Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients 2002 ·Journal of Affective Disorders ·Davangere P. Devanand, (unknown), Jocelyn Y. Cheng, Tal Burt, Gregory H. Pelton, Steven P. Roose, Harold A. Sackeïm	41
16	A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder 2000 ·Archives of General Psychiatry ·Christopher J. McDougle, C. Neill Epperson, Gregory H. Pelton, Suzanne Wasylink, Lawrence H. Price	384
17	Limited Efficacy of Ketoconazole in Treatment-Refractory Major Depression 1999 ·Journal of Clinical Psychopharmacology ·Robert T. Malison, Amit Anand, Gregory H. Pelton, Paul D. Kirwin, Linda L. Carpenter, Christopher J. McDougle, George R. Heninger, Lawrence H. Price	44
18	A Double-blind, Placebo-Controlled Study of Risperidone in Adults With Autistic Disorder and Other Pervasive Developmental Disorders 1998 ·Archives of General Psychiatry ·Christopher J. McDougle, (unknown), (unknown), Gregory H. Pelton, Donald J. Cohen, Lawrence H. Price	268
19	Resident and Faculty Evaluations of a Psychiatry Night-Float System 1996 ·Academic Psychiatry ·Benjamin G. Druss, Gregory H. Pelton, (unknown), William H. Sledge	5
20	No requirement of cyclic conformation of antagonists in binding to vasopressin receptors 1987 ·Nature ·M. Manning, Jacek Przybylski, Aleksandra Olma, Wieslaw A. Kliś, Marian Kruszynski, Nga Ching Wo, Gregory H. Pelton, W. H. Sawyer	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact